Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Bruce Crawford's publication output changed over time?
ScholarIQpublication output · 1999–2021
Output declined50% over the shown period — from 2 works in 1999 to 1 in 2021.
2
1
1
3
1
1
1
1
19992000200320082010201720192021
What are the most-cited papers on Bruce Crawford?
ScholarIQmost cited works
PRO development: rigorous qualitative research as the crucial foundation
Kathryn Lasch, Patrick Marquis, M Vigneux, Linda Abetz, Benoît Arnould, Martha Bayliss, Bruce Crawford, Kathleen Rosa
Quality of Life Research. 2010464 CitationsOPEN ACCESS
Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons
Jeroen P. Jansen, Bruce Crawford, Gert Bergman, Wiro B. Stam
Value in Health. 2008414 Citations
Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report
Allan Wailoo, Mónica Hernández Alava, Andrea Manca, Aurelio Mejía, Joshua Ray, Bruce Crawford, Marc Botteman, Jan J.V. Busschbach
Value in Health. 2017212 CitationsOPEN ACCESS
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial
Peter Tugwell, George Wells, Vibeke Strand, Andreas Maetzel, Claire Bombardier, Bruce Crawford, Catherine Dorrier, Ann Thompson
S132787887. 2000174 Citations
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
John Brazier, Roberta Ara, Ismail Azzabi, Jan J.V. Busschbach, Hélène Chevrou‐Séverac, Bruce Crawford, Luciane Nascimento Cruz, John Karnon, Andrew Lloyd, Suzy Paisley, A. Simon Pickard
Value in Health. 2019169 CitationsOPEN ACCESS
Related on ScholarIQ
PRO development: rigorous qualitative research as the crucial foundation
Paper
Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons
Paper
Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report
Paper
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial
Paper
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
Paper
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial
Paper